-
Genomma Lab Internacional Announces Results for the Third Quarter 2026
MEXICO CITY, Oct. 21, 2026 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma” or “the Company”), today announced its results for the third quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with… Source: Read More
-
Genomma Lab Internacional Secures Strategic Long-Term Debt Financing
Strengthening Financial Foundations Genomma Lab Internacional, a prominent player in the pharmaceutical and personal care industry, has officially announced the completion of a significant long-term debt transaction. This strategic financial maneuver is designed to bolster the company’s capital structure and support its ongoing operational objectives. Key Details of the Transaction The company has utilized this…